Uracil Breath Test

Drug Profile

Uracil Breath Test

Alternative Names: 13C-Uracil breath test; C13-URA

Latest Information Update: 01 Jun 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Otsuka Pharmaceutical
  • Class Antineoplastics; Nitrogen mustard compounds; Pyrimidinones
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Cancer; Gastrointestinal motility disorders

Most Recent Events

  • 31 Dec 2015 Discontinued - Phase-II for Gastrointestinal motility disorders (Diagnosis) in USA (PO)
  • 30 Sep 2015 Phase-II clinical trials in Gastrointestinal motility disorders (Diagnosis) in USA (PO) before September 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top